Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Duodenal Ulcer × Clear all
NCT02153398 2017-01-19

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

AstraZeneca

Phase 3 Completed
55 enrolled 31 charts
Gastrointestinal

Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01434485 2014-04-16

Nexium Capsules Clinical Experience Investigation

AstraZeneca

Completed
3,691 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01435525 2014-04-16

Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

AstraZeneca

Completed
369 enrolled
Gastrointestinal

Duodenal Ulcer, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡